Lila Sciences expanded its Series A with an additional $115 million — including investment from Nvidia’s venture arm — bringing the startup’s haul to $350 million. Lila, founded by Flagship Pioneering, is building a so‑called scientific 'superintelligence' platform that links biological data and generative models to design molecules and materials. The infusion highlights continued investor willingness to fund high‑risk, high‑capex AI‑for‑biology plays and underscores Nvidia’s growing role as a strategic investor in AI companies across life sciences.